Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Sutton

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Internal Medicine|September 25, 1999
Therapeutic plasma exchange: an update from the Canadian Apheresis GroupW F Clark, G A Rock, N Buskard, et al.
Experimental Hematology|March 1, 1991
GM-CSF therapy for delayed engraftment after autologous bone marrow transplantationJ M Brandwein, R Nayar, M A Baker, et al.
Bone Marrow Transplantation|September 11, 1998
Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantationA D Schimmer, A K Stewart, A Keating, et al.
Cancer Research|January 1, 1984
Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phaseM A Baker, R N Taub, W H Carter, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
A controlled trial evaluating intensive plasma exchange in renal transplant recipientsC J Cardella, D M Sutton, A Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplantM Crump, A M Smith, J Brandwein, et al.
Archives of Internal Medicine|May 9, 1994
Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndromeC P Hayward, D M Sutton, W H Carter, et al.
Bone Marrow Transplantation|January 11, 2000
Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myelomaR Abraham, C Chen, R Tsang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantationR Colwill, M Crump, F Couture, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2023
Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005W F Clark, A K Stewart, G A Rock, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Internal Medicine|September 25, 1999
Therapeutic plasma exchange: an update from the Canadian Apheresis GroupW F Clark, G A Rock, N Buskard, et al.
Experimental Hematology|March 1, 1991
GM-CSF therapy for delayed engraftment after autologous bone marrow transplantationJ M Brandwein, R Nayar, M A Baker, et al.
Bone Marrow Transplantation|September 11, 1998
Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantationA D Schimmer, A K Stewart, A Keating, et al.
Cancer Research|January 1, 1984
Immunotherapy for chronic myelogenous leukemia: survival not affected by treatment in the stable phaseM A Baker, R N Taub, W H Carter, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1980
A controlled trial evaluating intensive plasma exchange in renal transplant recipientsC J Cardella, D M Sutton, A Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplantM Crump, A M Smith, J Brandwein, et al.
Archives of Internal Medicine|May 9, 1994
Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndromeC P Hayward, D M Sutton, W H Carter, et al.
Bone Marrow Transplantation|January 11, 2000
Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myelomaR Abraham, C Chen, R Tsang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantationR Colwill, M Crump, F Couture, et al.
Journal of the American Society of Nephrology : JASN|March 31, 2023
Plasma Exchange for Acute Renal Failure of Myeloma-Logical, Yet Ineffective: Plasma Exchange When Myeloma Presents as Acute Renal Failure. A Randomized, Controlled Trial. Ann Int Medicine 143: 777-784, 2005W F Clark, A K Stewart, G A Rock, et al.
Pageof 4